E Kanasuo, H Siiskonen, S Haimakainen… - Melanoma …, 2023 - journals.lww.com
There are conflicting results on the role of vitamin D system in cutaneous carcinogenesis. Therefore, it was investigated whether the use of oral vitamin D supplements associates with …
P Srichomchey, S Sukprasert, N Khulasittijinda… - in vivo, 2023 - iv.iiarjournals.org
Abstract Background/Aim: Vitamin D3 (VD3) affects the regulation of the immune system, including the differentiation and function of regulatory T-cells (Tregs). Tregs play an …
T Liu, J Huang, D Xu, Y Li - Annals of translational medicine, 2021 - ncbi.nlm.nih.gov
Background Postmenopausal osteoporosis, a common yet chronic systemic metabolic disease, has become a major public health problem due to life expectancy increasing …
C Christofi, L Lamnis, A Stark, H Palm… - Anticancer …, 2022 - ar.iiarjournals.org
Background/Aim: Vitamin D receptor (VDR), activated upon binding of 1, 25 (OH) 2D3, was described as a tumor suppressor in the skin. New biological functions of non-classical …
A Fassio, G Porciello, G Carioli, E Palumbo, S Vitale… - Reumatismo, 2024 - iris.univr.it
Objective. To report cross-sectionally serum levels of 25-hydroxyvitamin D [25 (OH) D] in women living in Italy within 12 months from breast cancer (BC) diagnosis. Methods. Baseline …
A Tsuji, S Yoshikawa, S Morikawa, Y Ikeda… - … of Targeted Anti …, 2023 - ncbi.nlm.nih.gov
Immunotherapy strategies targeting immune checkpoint molecules such as programmed cell death-1 (PD-1) and cytotoxic T-lymphocyte-associated protein-4 (CTLA-4) are …
Background/Aim: There are no clinically significant cutoff values of serum vitamin D levels and time points to predict the prognosis of colon cancer, particularly in patients who …
C Stephan, B Ralla, F Bonn, M Diesner, M Lein, K Jung - Cancers, 2022 - mdpi.com
Simple Summary Recent research on prostate cancer and vitamin D is controversial. We measured three vitamin D3 metabolites in 32 selected prostate cancer patients after surgery …